230 related articles for article (PubMed ID: 28745240)
1. Nuclear Factor Kappa-light-chain-enhancer of Activated B Cells (NF-κB) - a Friend, a Foe, or a Bystander - in the Neurodegenerative Cascade and Pathogenesis of Alzheimer's Disease.
Marwarha G; Ghribi O
CNS Neurol Disord Drug Targets; 2017; 16(10):1050-1065. PubMed ID: 28745240
[TBL] [Abstract][Full Text] [Related]
2. Neuronal Gene Targets of NF-κB and Their Dysregulation in Alzheimer's Disease.
Snow WM; Albensi BC
Front Mol Neurosci; 2016; 9():118. PubMed ID: 27881951
[TBL] [Abstract][Full Text] [Related]
3. UNVEILING THE COMPLEX ROLE OF NF-ΚB IN ALZHEIMER'S DISEASE: INSIGHTS INTO BRAIN INFLAMMATION AND POTENTIAL THERAPEUTIC TARGETS.
Verma Y; Sachdeva H; Kalra S; Kumar P; Singh G
Georgian Med News; 2023 Sep; (342):133-141. PubMed ID: 37991969
[TBL] [Abstract][Full Text] [Related]
4. Anti-Neuroinflammatory Potential of Polyphenols by Inhibiting NF-κB to Halt Alzheimer's Disease.
Uddin MS; Hasana S; Ahmad J; Hossain MF; Rahman MM; Behl T; Rauf A; Ahmad A; Hafeez A; Perveen A; Ashraf GM
Curr Pharm Des; 2021; 27(3):402-414. PubMed ID: 33213314
[TBL] [Abstract][Full Text] [Related]
5. NF-kappaB in the survival and plasticity of neurons.
Mattson MP
Neurochem Res; 2005; 30(6-7):883-93. PubMed ID: 16187223
[TBL] [Abstract][Full Text] [Related]
6. Potential therapeutic targets in the NF-kappaB pathway for Alzheimer's disease.
Collister KA; Albensi BC
Drug News Perspect; 2005 Dec; 18(10):623-9. PubMed ID: 16491164
[TBL] [Abstract][Full Text] [Related]
7. Transcription factor NF-kappaB: friend or foe of neurons?
Lezoualc'h F; Behl C
Mol Psychiatry; 1998 Jan; 3(1):15-20. PubMed ID: 9491808
[TBL] [Abstract][Full Text] [Related]
8. NF-κB as a Key Mediator of Brain Inflammation in Alzheimer's Disease.
Ju Hwang C; Choi DY; Park MH; Hong JT
CNS Neurol Disord Drug Targets; 2019; 18(1):3-10. PubMed ID: 28782486
[TBL] [Abstract][Full Text] [Related]
9. Roles of nuclear factor kappaB in neuronal survival and plasticity.
Mattson MP; Culmsee C; Yu Z; Camandola S
J Neurochem; 2000 Feb; 74(2):443-56. PubMed ID: 10646495
[TBL] [Abstract][Full Text] [Related]
10. NF-κB Pathway and Its Inhibitors: A Promising Frontier in the Management of Alzheimer's Disease.
Sivamaruthi BS; Raghani N; Chorawala M; Bhattacharya S; Prajapati BG; Elossaily GM; Chaiyasut C
Biomedicines; 2023 Sep; 11(9):. PubMed ID: 37761028
[TBL] [Abstract][Full Text] [Related]
11. Significance of NF-κB as a pivotal therapeutic target in the neurodegenerative pathologies of Alzheimer's disease and multiple sclerosis.
Srinivasan M; Lahiri DK
Expert Opin Ther Targets; 2015 Apr; 19(4):471-87. PubMed ID: 25652642
[TBL] [Abstract][Full Text] [Related]
12. BAG-1M co-activates BACE1 transcription through NF-κB and accelerates Aβ production and memory deficit in Alzheimer's disease mouse model.
Shi Z; Hong Y; Zhang K; Wang J; Zheng L; Zhang Z; Hu Z; Han X; Han Y; Chen T; Yao Q; Cui H; Hong W
Biochim Biophys Acta Mol Basis Dis; 2017 Sep; 1863(9):2398-2407. PubMed ID: 28502705
[TBL] [Abstract][Full Text] [Related]
13. Nuclear factor-kappa β as a therapeutic target for Alzheimer's disease.
Jha NK; Jha SK; Kar R; Nand P; Swati K; Goswami VK
J Neurochem; 2019 Jul; 150(2):113-137. PubMed ID: 30802950
[TBL] [Abstract][Full Text] [Related]
14. Every Cloud Has a Silver Lining: Proneurogenic Effects of Aβ Oligomers and HMGB-1 via Activation of the RAGE-NF-κB Axis.
Bortolotto V; Grilli M
CNS Neurol Disord Drug Targets; 2017; 16(10):1066-1079. PubMed ID: 27488419
[TBL] [Abstract][Full Text] [Related]
15. Brain region- and sex-specific alterations in mitochondrial function and NF-κB signaling in the TgCRND8 mouse model of Alzheimer's disease.
Djordjevic J; Thomson E; Chowdhury SR; Snow WM; Perez C; Wong TP; Fernyhough P; Albensi BC
Neuroscience; 2017 Oct; 361():81-92. PubMed ID: 28802916
[TBL] [Abstract][Full Text] [Related]
16. Interaction of NF-κB and Wnt/β-catenin Signaling Pathways in Alzheimer's Disease and Potential Active Drug Treatments.
Liu X; Wang K; Wei X; Xie T; Lv B; Zhou Q; Wang X
Neurochem Res; 2021 Apr; 46(4):711-731. PubMed ID: 33523396
[TBL] [Abstract][Full Text] [Related]
17. Iron, neuroinflammation, and Alzheimer's disease.
Ong WY; Farooqui AA
J Alzheimers Dis; 2005 Nov; 8(2):183-200; discussion 209-15. PubMed ID: 16308487
[TBL] [Abstract][Full Text] [Related]
18. Honokiol Attenuates Oligomeric Amyloid β1-42-Induced Alzheimer's Disease in Mice Through Attenuating Mitochondrial Apoptosis and Inhibiting the Nuclear Factor Kappa-B Signaling Pathway.
Wang M; Li Y; Ni C; Song G
Cell Physiol Biochem; 2017; 43(1):69-81. PubMed ID: 28848085
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional Control of Synaptic Plasticity by Transcription Factor NF-κB.
Engelmann C; Haenold R
Neural Plast; 2016; 2016():7027949. PubMed ID: 26881128
[TBL] [Abstract][Full Text] [Related]
20. Upstream regulators and downstream effectors of NF-κB in Alzheimer's disease.
Shi ZM; Han YW; Han XH; Zhang K; Chang YN; Hu ZM; Qi HX; Ting C; Zhen Z; Hong W
J Neurol Sci; 2016 Jul; 366():127-134. PubMed ID: 27288790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
